TrialAntimicrobial agents and chemotherapy2015

First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity.

Shirin Bruderer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.